Healthy Extracts (HYEX) Net Equity Issued and Repurchased (2015 - 2023)

Healthy Extracts' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at -$55000.0 for Q4 2023.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$55000.0 in Q4 2023; TTM through Sep 2024 was -$55000.0, a 57.14% decrease from a year earlier, with the FY2023 full-year figure at -$90000.0, down 690.44% from the prior year.
• Net Equity Issued and Repurchased declined to -$55000.0 in Q4 2023 per HYEX's latest filing, from -$35000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $2.1 million in Q3 2020 and bottomed at -$1.7 million in Q4 2020.
• The 4-year median for Net Equity Issued and Repurchased is -$31708.5 (2022), against an average of $124517.6.
• Across the five-year window, Net Equity Issued and Repurchased jumped 144.39% in 2021 and plunged 164.54% in 2023, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at -$1.7 million in 2020, then surged by 144.39% to $770199.0 in 2021, then sank by 92.96% to $54231.0 in 2022, then slumped by 201.42% to -$55000.0 in 2023.
• Per Business Quant, the three latest HYEX Net Equity Issued and Repurchased figures stand at -$55000.0 (Q4 2023), -$35000.0 (Q3 2023), and $54231.0 (Q3 2022).